AI-24431/AI/NIAID NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1991	1
1992	1
1993	1
1995	2
2002	2
2003	1
2005	2
2021	0

1

Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells.

Brito GA, Fujji J, Carneiro-Filho BA, Lima AA, Obrig T, Guerrant RL. Brito GA, et al. J Infect Dis. 2002 Nov 15;186(10):1438-47. doi: 10.1086/344729. Epub 2002 Oct 29. J Infect Dis. 2002. PMID: 12404159

2

Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function.

Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Keepers TR, Obrig T, Gear AR. Guessous F, et al. Thromb Haemost. 2005 Nov;94(5):1019-27. doi: 10.1160/TH05-02-0115. Thromb Haemost. 2005. PMID: 16366002

3

The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells.

Houpt ER, Glembocki DJ, Obrig TG, Moskaluk CA, Lockhart LA, Wright RL, Seaner RM, Keepers TR, Wilkins TD, Petri WA Jr. Houpt ER, et al. J Immunol. 2002 Oct 15;169(8):4496-503. doi: 10.4049/jimmunol.169.8.4496. J Immunol. 2002. PMID: 12370386 Free article.

4

Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells.

Obrig TG, Seaner RM, Bentz M, Lingwood CA, Boyd B, Smith A, Narrow W. Obrig TG, et al. Infect Immun. 2003 Feb;71(2):845-9. doi: 10.1128/iai.71.2.845-849.2003. Infect Immun. 2003. PMID: 12540565 Free PMC article.

5

Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.

Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG. Kaye SA, et al. Infect Immun. 1993 Sep;61(9):3886-91. doi: 10.1128/IAI.61.9.3886-3891.1993. Infect Immun. 1993. PMID: 8359910 Free PMC article.

6

Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.

Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Kongkhum S, Heatherly D, Obrig T, Gear AR. Guessous F, et al. Infect Immun. 2005 Dec;73(12):8306-16. doi: 10.1128/IAI.73.12.8306-8316.2005. Infect Immun. 2005. PMID: 16299328 Free PMC article.

7

Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.

Louise CB, Obrig TG. Louise CB, et al. Infect Immun. 1992 Apr;60(4):1536-43. doi: 10.1128/IAI.60.4.1536-1543.1992. Infect Immun. 1992. PMID: 1548077 Free PMC article.

8

Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Louise CB, Obrig TG. Louise CB, et al. Infect Immun. 1991 Nov;59(11):4173-9. doi: 10.1128/IAI.59.11.4173-4179.1991. Infect Immun. 1991. PMID: 1937774 Free PMC article.

9

Effect of TNF-alpha, Shiga toxin and calcium ionophore on Weibel-Palade body content of endothelial cells: possible implications for the hemolytic uremic syndrome.

Kaye SA, Obrig TG. Kaye SA, et al. Thromb Res. 1995 Aug 15;79(4):415-21. doi: 10.1016/0049-3848(95)00130-j. Thromb Res. 1995. PMID: 7482445 No abstract available.

10

Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.

Louise CB, Obrig TG. Louise CB, et al. J Infect Dis. 1995 Nov;172(5):1397-401. doi: 10.1093/infdis/172.5.1397. J Infect Dis. 1995. PMID: 7594687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results